 Eric Earley
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Limbs | 13 | 2025 | 176 | 5.560 |
Why?
| | Prosthesis Design | 9 | 2025 | 309 | 1.800 |
Why?
| | Electromyography | 7 | 2025 | 400 | 1.740 |
Why?
| | Erythrocytes | 8 | 2025 | 693 | 1.570 |
Why?
| | Feedback, Sensory | 5 | 2023 | 23 | 1.570 |
Why?
| | Amputees | 3 | 2024 | 83 | 1.430 |
Why?
| | Prosthesis Implantation | 5 | 2024 | 153 | 1.050 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 546 | 1.000 |
Why?
| | Upper Extremity | 3 | 2025 | 102 | 0.950 |
Why?
| | Bionics | 2 | 2024 | 12 | 0.940 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2024 | 32 | 0.910 |
Why?
| | Introns | 1 | 2024 | 256 | 0.830 |
Why?
| | Hemolysis | 5 | 2025 | 205 | 0.710 |
Why?
| | Cochlear Implantation | 1 | 2022 | 93 | 0.680 |
Why?
| | Cochlear Implants | 1 | 2022 | 110 | 0.670 |
Why?
| | Blood Preservation | 4 | 2025 | 282 | 0.570 |
Why?
| | Joints | 1 | 2018 | 105 | 0.570 |
Why?
| | Movement | 5 | 2022 | 273 | 0.550 |
Why?
| | Forearm | 1 | 2017 | 120 | 0.530 |
Why?
| | Psychomotor Performance | 1 | 2019 | 326 | 0.510 |
Why?
| | Hand | 4 | 2023 | 160 | 0.500 |
Why?
| | Blood Donors | 2 | 2025 | 103 | 0.430 |
Why?
| | Phantom Limb | 2 | 2024 | 5 | 0.420 |
Why?
| | Pattern Recognition, Automated | 1 | 2014 | 76 | 0.420 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 658 | 0.360 |
Why?
| | Robotics | 2 | 2023 | 96 | 0.330 |
Why?
| | Electrodes, Implanted | 4 | 2023 | 116 | 0.330 |
Why?
| | Humans | 29 | 2025 | 137514 | 0.310 |
Why?
| | Feedback | 2 | 2023 | 174 | 0.240 |
Why?
| | Communicable Diseases, Emerging | 1 | 2025 | 35 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 32 | 0.230 |
Why?
| | Learning | 2 | 2019 | 430 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 60 | 0.220 |
Why?
| | Diazooxonorleucine | 1 | 2024 | 2 | 0.220 |
Why?
| | Canada | 1 | 2025 | 421 | 0.220 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 201 | 0.210 |
Why?
| | Boron Compounds | 1 | 2024 | 27 | 0.210 |
Why?
| | Carnitine | 1 | 2024 | 83 | 0.210 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 26 | 0.210 |
Why?
| | Delphi Technique | 1 | 2025 | 273 | 0.210 |
Why?
| | Uric Acid | 1 | 2025 | 164 | 0.210 |
Why?
| | Neuroblastoma | 1 | 2024 | 161 | 0.210 |
Why?
| | Calcium-Binding Proteins | 1 | 2024 | 218 | 0.210 |
Why?
| | Immunoconjugates | 1 | 2024 | 116 | 0.200 |
Why?
| | Femur | 1 | 2025 | 263 | 0.200 |
Why?
| | Arginine | 1 | 2024 | 274 | 0.200 |
Why?
| | Glycine | 1 | 2024 | 175 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2025 | 146 | 0.200 |
Why?
| | Erythrocyte Transfusion | 1 | 2025 | 193 | 0.200 |
Why?
| | Sensation | 1 | 2023 | 54 | 0.200 |
Why?
| | Exercise Tolerance | 1 | 2025 | 278 | 0.200 |
Why?
| | Elbow | 1 | 2023 | 57 | 0.200 |
Why?
| | Glycolysis | 1 | 2024 | 319 | 0.190 |
Why?
| | Wrist | 1 | 2023 | 54 | 0.190 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2024 | 191 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 255 | 0.190 |
Why?
| | Consensus | 1 | 2025 | 685 | 0.190 |
Why?
| | Electric Impedance | 1 | 2022 | 109 | 0.190 |
Why?
| | Neoplasm Proteins | 1 | 2025 | 433 | 0.180 |
Why?
| | Arm | 1 | 2022 | 106 | 0.180 |
Why?
| | Quality of Life | 2 | 2023 | 2870 | 0.170 |
Why?
| | Monitoring, Physiologic | 1 | 2022 | 267 | 0.170 |
Why?
| | Self Concept | 1 | 2022 | 260 | 0.170 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2024 | 2193 | 0.160 |
Why?
| | Male | 11 | 2025 | 67718 | 0.160 |
Why?
| | Biomedical Research | 1 | 2025 | 689 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2024 | 1167 | 0.140 |
Why?
| | Acclimatization | 1 | 2019 | 176 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2019 | 352 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1702 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 571 | 0.140 |
Why?
| | Female | 10 | 2025 | 73162 | 0.130 |
Why?
| | Task Performance and Analysis | 1 | 2017 | 186 | 0.130 |
Why?
| | Mice | 7 | 2025 | 17843 | 0.120 |
Why?
| | Aging | 1 | 2024 | 1866 | 0.110 |
Why?
| | Motor Activity | 1 | 2018 | 723 | 0.110 |
Why?
| | Mice, SCID | 2 | 2024 | 367 | 0.100 |
Why?
| | Wrist Joint | 1 | 2014 | 65 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4172 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 148 | 0.100 |
Why?
| | Hand Strength | 1 | 2014 | 122 | 0.100 |
Why?
| | Quantitative Trait Loci | 2 | 2025 | 381 | 0.100 |
Why?
| | Pain Measurement | 2 | 2024 | 552 | 0.090 |
Why?
| | Animals | 7 | 2025 | 37011 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2024 | 1987 | 0.070 |
Why?
| | Middle Aged | 5 | 2025 | 33355 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 12 | 0.060 |
Why?
| | Proteogenomics | 1 | 2024 | 3 | 0.060 |
Why?
| | Adult | 5 | 2025 | 37821 | 0.060 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 152 | 0.060 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.060 |
Why?
| | Hexokinase | 1 | 2024 | 19 | 0.060 |
Why?
| | Erythrocyte Aging | 1 | 2024 | 17 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2024 | 45 | 0.050 |
Why?
| | Isoenzymes | 1 | 2024 | 305 | 0.050 |
Why?
| | Heterografts | 1 | 2024 | 139 | 0.050 |
Why?
| | Titanium | 1 | 2023 | 82 | 0.050 |
Why?
| | Iron | 1 | 2025 | 313 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 325 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2024 | 892 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2024 | 601 | 0.050 |
Why?
| | Electric Stimulation | 1 | 2023 | 272 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2024 | 487 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2025 | 376 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2024 | 324 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 868 | 0.050 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 414 | 0.050 |
Why?
| | Anemia, Sickle Cell | 1 | 2024 | 266 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2024 | 414 | 0.040 |
Why?
| | Aged | 3 | 2024 | 23798 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 647 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2182 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 679 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2074 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 895 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1402 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1307 | 0.040 |
Why?
| | Proteomics | 1 | 2025 | 1113 | 0.040 |
Why?
| | Lower Extremity | 1 | 2022 | 427 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2024 | 1279 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1436 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3420 | 0.030 |
Why?
| | Pandemics | 1 | 2025 | 1619 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1999 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1701 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4295 | 0.030 |
Why?
| | Child | 2 | 2024 | 22037 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2024 | 10821 | 0.020 |
Why?
|
|
Earley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|